BSMIX
Price
$17.50
Change
-$0.08 (-0.46%)
Updated
Aug 15 closing price
Net Assets
1.03B
VSCPX
Price
$340.19
Change
-$1.26 (-0.37%)
Updated
Aug 15 closing price
Net Assets
154.18B
Interact to see
Advertisement

BSMIX vs VSCPX

Header iconBSMIX vs VSCPX Comparison
Open Charts BSMIX vs VSCPXBanner chart's image
iShares Russell Small/Mid-Cap Idx Instl
Price$17.50
Change-$0.08 (-0.46%)
VolumeN/A
Net Assets1.03B
Vanguard Small Cap Index InstlPlus
Price$340.19
Change-$1.26 (-0.37%)
VolumeN/A
Net Assets154.18B
BSMIX vs VSCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BSMIX vs. VSCPX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSMIX is a Hold and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 154B vs. BSMIX (1.03B). BSMIX (1.45) and VSCPX (1.39) have matching dividends . BSMIX was incepted earlier than VSCPX: BSMIX (10 years) vs VSCPX (15 years). BSMIX (0.14) is less costly to investors than VSCPX (0.03). BSMIX is a more actively managed with annual turnover of: 43.00 vs. VSCPX (13.00). BSMIX has a lower initial minimum investment than VSCPX: BSMIX (2000000) vs VSCPX (100000000). BSMIX (9.65) and VSCPX (9.18) have marching annual gain over last year. VSCPX return over 5 years is better than : 57.76 vs. BSMIX (46.91).
BSMIXVSCPXBSMIX / VSCPX
Total Expense Ratio0.130.03433%
Annual Report Gross Expense Ratio0.140.03467%
Fund Existence10 years15 years-
Gain YTD4.6202.528183%
Front LoadN/AN/A-
Min. Initial Investment20000001000000002%
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B154B1%
Annual Yield % from dividends1.451.39104%
Returns for 1 year9.659.18105%
Returns for 3 years17.8620.5087%
Returns for 5 years46.9157.7681%
Returns for 10 years97.31113.1986%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI5.921.27
+27.31%
Karyopharm Therapeutics Inc.
EWTX14.150.22
+1.58%
Edgewise Therapeutics
RYAN59.12-0.39
-0.66%
Ryan Specialty Holdings
MBINM25.19-0.18
-0.72%
Merchants Bancorp
ALT3.63-0.05
-1.36%
Altimmune